高级搜索
    删除搜索历史记录.
    我的图书馆

    RandomizedPhaseIIIStudyComparingPaclitaxel/Cisplatin/ GemcitabineandGemcitabine/CisplatininPatientsWithLocally AdvancedorMetastaticUrothelialCancerWithoutPriorSystemic Therapy:EORTCIntergroupStudy30987

    作者： Sandrine Marreaud , Luis Paz-Ares , Iwona Skoneczna , Sandra Collette , Eric Winquist

    DOI:

    关键词:

    摘要: Purpose The combination of gemcitabine plus cisplatin (GC) is a standard regimen in patients with locally advanced or metastatic urothelial cancer. A phase I/II study suggested that three-drug included paclitaxel had greater antitumor activity and might improve survival.

    参考文章(25)
    1.
    2.
    W M Stadler, T Kuzel, B Roth, D Raghavan, F A Dorr, Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer. Journal of Clinical Oncology. ,vol. 15, pp. 3394- 3398 ,(1997) , 10.1200/JCO.1997.15.11.3394
    3.
    Dean F. Bajorin, Paul M. Dodd, Madhu Mazumdar, Melissa Fazzari, John A. McCaffrey, Howard I. Scher, Harry Herr, Geralyn Higgins, Mary G. Boyle, Long-Term Survival in Metastatic Transitional-Cell Carcinoma and Prognostic Factors Predicting Outcome of Therapy Journal of Clinical Oncology. ,vol. 17, pp. 3173- 3181 ,(1999) , 10.1200/JCO.1999.17.10.3173
    4.
    M J Moore, I F Tannock, D S Ernst, S Huan, N Murray, Gemcitabine: a promising new agent in the treatment of advanced urothelial cancer. Journal of Clinical Oncology. ,vol. 15, pp. 3441- 3445 ,(1997) , 10.1200/JCO.1997.15.12.3441
    5.
    A D Seidman, H I Scher, J L Gabrilove, D F Bajorin, R J Motzer, M O'Dell, T Curley, D D Dershaw, S Quinlivan, Y Tao, Dose-intensification of MVAC with recombinant granulocyte colony-stimulating factor as initial therapy in advanced urothelial cancer Journal of Clinical Oncology. ,vol. 11, pp. 408- 414 ,(1993) , 10.1200/JCO.1993.11.3.408
    6.
    P J Loehrer, L H Einhorn, P J Elson, E D Crawford, P Kuebler, I Tannock, D Raghavan, R Stuart-Harris, M F Sarosdy, B A Lowe, A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. Journal of Clinical Oncology. ,vol. 10, pp. 1066- 1073 ,(1992) , 10.1200/JCO.1992.10.7.1066
    7.
    B J Roth, R Dreicer, L H Einhorn, D Neuberg, D H Johnson, J L Smith, G R Hudes, S M Schultz, P J Loehrer, Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium: a phase II trial of the Eastern Cooperative Oncology Group. Journal of Clinical Oncology. ,vol. 12, pp. 2264- 2270 ,(1994) , 10.1200/JCO.1994.12.11.2264
    8.
    C J Logothetis, F H Dexeus, L Finn, A Sella, R J Amato, A G Ayala, R G Kilbourn, A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors. Journal of Clinical Oncology. ,vol. 8, pp. 1050- 1055 ,(1990) , 10.1200/JCO.1990.8.6.1050
    9.
    Joaquim Bellmunt, Antoni Ribas, Natalia Eres, Joan Albanell, Concepci�n Almanza, Bego�a Bermejo, Luis-Alfonso Sol�, Jos� Baselga, Carboplatin-based versus cisplatin-based chemotherapy in the treatment of surgically incurable advanced bladder carcinoma Cancer. ,vol. 80, pp. 1966- 1972 ,(1997) , 10.1002/(SICI)1097-0142(19971115)80:10<1966::AID-CNCR14>3.0.CO;2-W
    10.
    Amber E. Hudson, Waldo C. Feng, Catherine F. Delostrinos, Nicole Carmean, James A. Bassuk, Spreading of embryologically distinct urothelial cells is inhibited by SPARC. Journal of Cellular Physiology. ,vol. 202, pp. 453- 463 ,(2005) , 10.1002/JCP.20140
    来源期刊
    • 2012 年,
    • Volume: , Issue: ,
    • Page:
    相似文章 0
      学术资源搜索(ver.BATE)

      为学术研究人员、学生以及专业人士设计的在线资源检索工具。
      致力于为用户提供全球范围内高质量开放学术文献、研究报告、会议论文、期刊文章等学术资源的便捷访问.

      Copyright © 2023. KipHub all right reserved. 沪ICP备2023020492号-1
      联系方式Terms & ConditionsSecurity
      Copyright 2023 ©KipHub.